China Tianbao Group 2025 Results: Revenue Falls 16.7%, Loss Narrows; No Final Dividend Declared

Bulletin Express
03/31

China Tianbao Group Development Company Limited (CH TIANBAO GP, 01427) reported FY-2025 revenue of RMB 1.70 billion, down 16.7% year-on-year, as softer construction activity and a sluggish property market outweighed the first-time contribution from its healthcare segment.

Gross profit slipped 12.9% to RMB 47.66 million, but the gross margin edged up to 2.8% (2024: 2.7%). The group trimmed its underlying loss to RMB 122.04 million from RMB 161.54 million a year earlier; reported loss narrowed to RMB 123.88 million (2024: RMB 165.55 million). Loss per share improved to RMB 0.14 cents (2024: RMB 0.20 cents).

Segment performance • Construction contracting – Revenue fell 18.3% to RMB 1.53 billion, representing 90.0% of group turnover; gross margin improved to 6.5%. • Property development & others – Revenue was stable at RMB 169.26 million, but impairments on inventories and receivables pushed the segment to a gross loss. • Healthcare – The newly launched Tianbao Jingbei Health City contributed RMB 1.09 million in its first eight months of operation, posting an initial gross loss due to start-up costs.

Balance-sheet highlights • Cash and cash equivalents (including RMB 163.47 million pledged deposits) stood at RMB 393.54 million (2024: RMB 419.90 million). • Interest-bearing bank and other borrowings increased to RMB 1.44 billion (2024: RMB 1.36 billion); net debt rose to RMB 1.05 billion. • Net current liabilities narrowed to RMB 203.45 million (2024: RMB 324.45 million). • Gearing ratio climbed to 188.2%, while net gearing reached 136.8%.

Operational metrics • New construction contracts signed during 2025 totaled RMB 1.81 billion; year-end backlog stood at RMB 8.49 billion. • Property land bank measured 593,381 sq.m., of which 58% is in Zhuozhou and 42% in Zhangjiakou. • The healthcare arm now operates 350 hospital beds and 1,500 elderly-care beds; further phases aim to lift capacity to 8,800 beds.

Dividend & outlook The board proposed no final dividend for FY-2025. Management plans to tighten cost control, pursue cash-generating construction projects, and engage lenders for debt extensions to address going-concern uncertainties highlighted by auditors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10